CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
DACP MF +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02403180
NCT02403180N/ACompleted
CompareCT.gov

Comparative Assessment of Visual Performance Between DAILIES® AquaComfort Plus® (DACP) Multifocal (MF) and PROCLEAR 1 Day Multifocal (PROCLEAR 1D MF)

Alcon Research·interventional·Posted Mar 31, 2015·Updated Aug 18, 2016

In Brief

A clinical study evaluating DACP MF and PROCLEAR 1D MF for Presbyopia. Completed, enrolled 70 participants.

Detailed Summary

The purpose of this study is to evaluate the visual performance of DACP MF and PROCLEAR 1D MF daily disposable contact lenses in an established presbyopic population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 31, 2015
Enrollment StartMay 1, 2015
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 11.3 years ago

Interventions

DACP MFdevice

Nelfilcon A multifocal contact lenses

PROCLEAR 1D MFdevice

Omafilcon A multifocal contact lenses